To whom reprint requests should be sent Normal human urinary tract epithelial cells (HUC) were neoplastically transformed in vitro using a step-wise strategy. First, a partially transformed non-virus-producing cell line was obtained after infection of HUC with simian virus 40 (SV40). This cell line (SV-HUC-1) was demonstrated to be clonal in origin, as 100% of cells contained at least five of seven marker chromosomes. Marker chromosomes were formed by balanced translocations resulting in a 'pseudodiploid' cell line. SV-HUC-1 showed altered growth properties in vitro (e.g. anchorage independent growth) but failed to form tumors in athymic nude mice, even after 3 years in culture (80 passages). In the studies reported here, SV-HUC-1 at early passages (P15-P19) were exposed to 3-methylcholanthrene (MCA) in three separate experiments. After a six-week post-treatment period of cell culture, cells were inoculated s.c. into athymic nude mice. In all experiments, MCA-treated SV-HUC-1 formed carcinomas in mice usually with a latent period of 5-8 weeks. These carcinomas showed heterogeneity with respect to histopathologies and growth properties in the mice and karyotypes. All the tumors retained SV-HUC-1 chromosome markers, but each independent transformant was aneuploid and contained unique new marker chromosomes. Chromosomes usually altered in tumor cells included numbers 3, 5, 6, 9,11 and 13. Mutations in the ras family of cellular proto-oncogenes resulting in altered mobility of the p21 protein product were not detected in six cell lines established from independently derived tumors. It is not yet known whether other cellular protooncogenes are activated in these tumorigenic transformants. Neither control SV-HUC-1 (which were not exposed to MCA), nor early passage HUC exposed to MCA formed tumors when inoculated into mice. Thus, the tumorigenic transformation of HUC resulted from the combined actions of SV40 and MCA.
Introduction
Bladder cancer accounts for only 4% of human malignancies, but is the third most prevalent cancer type among men 60 years of age and older (1, 2) . The development and progression of bladder cancer illustrates several general principles which are applicable to many common human cancers. For example, bladder cancers develop primarily in the epithelial cells of the organ (3), as do 90% of adult human cancers (4) . Some epidemiologists estimate that 10-50% of all human bladder cancers result from exposure to environmental carcinogens (5) . Many bladder-specific chemical carcinogens have been identified. For example, exposure to some arylamines (formerly used in industry) increases the risk of bladder cancer 10-to 50-fold (6, 7) , while smoking increases the risk factor 2-to 6-fold (8, 9) . The development of bladder cancer after exposure to such carcinogens may take decades and is related to the dose and duration of exposure (6, 8) . Epidemiological, histopathological and clinical studies show that the pathogenesis of bladder carcinoma is frequently multistage in nature (10) . Preneoplastic bladder changes and/or superficial tumors sometimes precede malignancy, but patients with such conditions do not always develop bladder cancer (11) . Heterogeneity in the histopathologies and growth properties of bladder cancers are common (12) . Despite recent advances in chemotherapy, the age-adjusted incidence of death from bladder cancers has not decreased significantly in the last 50 years (1).
Very little is known concerning the molecular and cytogenetic mechanisms of human bladder carcinogenesis. Recent studies have shown that the c-Ha-ras-1 cellular proto-oncogene is activated in ~ 10% of human bladder cancers (13) (14) (15) , but the role, if any, of alterations in ras genes in the development of bladder cancers has not been established. Loss of genes on the short arm of chromosome 11 have been observed in some bladder cancers (16) . Some reports suggest that certain chromosomes may be more commonly altered in bladder cancers (17) (18) (19) , but no definitive diagnostic cytogenetic changes have yet been identified. Therefore, there is good rationale to develop experimental systems to investigate the genetic mechanisms of multistage human bladder carcinogenesis. However, in vitro systems for mechanistic studies of human epithelial cell carcinogenesis have been difficult to develop (20) . Recent studies suggest that in keeping with the multistep development of carcinomas in vivo, a stepwise approach to neoplastic transformation in vitro presents a reasonable strategy (21, 22) . In the present report, we demonstrate that an established line (23) of simian virus 40 (SV40*) immortalized human uroepithelial cells (SV-HUC-1) can be reproducibly neoplastically transformed in vitro by exposure to the polycyclic hydrocarbon, 3-methylcholanthrene (MCA), but non-established normal human uroepithelial cells (HUC) are not transformed using the same protocol. The SV-HUC-1 cell line used in these studies was clonal in origin and has a pseudodiploid karyotype; therefore, cytogenetic changes associated with tumorigenic transformation were easily identifiable. SV-HUC-1 cells did not spontaneously transform even after many passages (>80) in vitro but neoplastic transformation was readily reproduced by treatment of cells with MCA. The characteristics of the in vitro transformants produced in these studies reflected to some extent the heterogeneous properties of human clinical bladder cancers.
Materials and methods
Initiation and culture of HUC Primary explant cultures of HUC were initiated from pieces of ureteral uroepithelium which were left over at the time of kidney transplantation surgery. Methods of culturing HUC have been described (24) (25) (26) (27) . Briefly, the epithelial layer of the ureter was mechanically stripped from the underlying stromal tissue and cut into 1-mm 2 explants. Explants were plated onto ammonia-reconstituted type I rat-tail collagen-gel substrates in 100-mm plastic dishes (Nunc, Kamstrup, Denmark) which were pre-equilibrated with medium. After an 8-12-h period in a small volume of medium to facilitate explant attachment, 10 ml of culture medium was added to each Petri dish. The medium used was Ham's F12 (Gibco, Grand Island, NY) supplemented with 1 jig/ml hydrocortisone (Merck, Sharp and Dohme, West Point, PA), 5 /tg/ml transferrin (Sigma Chemical Co., St Louis, MO), 10 /ig/ml insulin (Squibb-Novo, Inc., Princeton, NJ), 0.1 mM non-essential amino acids (Microbiological Associates, Walkersville, MD), 2 mM glutamine (Gibco), 2.7 mg/ml D-glucose (Amend Drug and Chemical Co., Irvington, NJ), 100 U/ml penicillin (Pfizer, Inc., New York, NY), and 100 ftg/ml streptomycin (Pfizer). Fetal bovine serum (FBS; Hy-Clone, Logan, UT) was also added (except as noted below) to the F12+ medium at a final concentration of 1 %. The culture medium (1% FBS-F12+) was changed three times weekly. For serial passage and initiation of experiments, cells were dispersed using 0.1 % ethylenediamine tetraacetic acid (EDTA; Sigma). Cultures were maintained in humidified incubators at 37 °C in an atmosphere of 5% CO 2 and 95% air. These conditions are apparently selective for the growth of uroepithelial cells as they do not support the outgrowth of fibroblastic cells from human ureteral explants (26) . Dispersed cells were stained with 0.4% trypan blue (Gurr, Bucks, UK) for 5 min and examined microscopically using hemocytometers to determine cell numbers and viabilities.
Culture of SV-HUC-1
The establishment of in vitro and characteristics of the SV-HUC-1 human uroepithelial cell line which was used for the neoplastic transformation studies reported herein have been described (23) . Features essential to the present report are briefly summarized. The ureter used to initiate the cultures from which the SV-HUC-1 cell line was derived came from an 11-year-old male accident victim whose kidneys were donated for transplantation. Since the incidence of bladder cancer in young children is extremely rare (28) , there is little chance that this tissue contained neoplastic or preneoplastic uroepithelial cells. These HUC were infected with wild-type SV40 virus. Control cultures from the same tissue donor were mock infected. The SV40-transformed cells were selected by their ability to grow beyond the time when all the control cells spontaneously senesced. The apparently immortal (>80 passages, 3 years in culture) cell line (SV-HUC-1) which was derived from this experiment was 100% positive for SV40 T-antigen and for human epithelial keratins and was negative for the production of infectious SV40. SV-HUC-1 cells have remained non-tumorigenic through 80 passages in vitro. Once established (> PI2), SV-HUC-1 required neither a collagen substrate nor the supplemented F12 + medium (described above) for maximum cell growth (23) . In the experiments reported here, early passage SV-HUC-1 (P15-P19) were used and were grown in 1% FBS -F12+ on plastic dishes. Medium was changed three times weekly and cells were dispersed using 0.1 % EDTA. Samples of SV-HUC-1 cells at several early passages were cryopreserved in liquid nitrogen.
Quantitative assessment of MCA-induced cytotoxicity
The purity of the MCA (Aldnch Chemical Co., Milwaukee, WI) was determined to be >99% by HPLC (280 nm detection wavelength). The cytotoxic effects of MCA towards HUC and SV-HUC-1 were determined by quantitative measurements of growth inhibition (29) . Cultures of HUC or SV-HUC-1 (at the passages indicated in each transformation experiment) were seeded at 1.0 x 10 5 cells/60-mm dish using culture conditions described above for each cell type. Forty-eight hours after seeding, the medium was changed to serum-free F12 + , and the indicated concentrations of MCA dissolved in a final concentration of 0.5% dimethylsulfoxide (DMSO; Aldrich) were added to each culture for a 48-h exposure period. FBS (1%) was added back to the culture medium 24 h after addition of MCA. After a total exposure period of 48 h, the medium containing the carcinogen was removed, the cultures were rinsed, fresh medium was added, and cells were cultured for 5 -7 days with routine changes of medium. Cells were then dispersed and counted. The numbers of viable cells in the carcinogentreated groups were compared to the numbers of viable cells in the control groups to determine relative percent cytotoxicity. Triplicate samples were used for each cytotoxicity determination, and results are presented as the average relative cell survival (x ± SD).
Protocols for the transformation experiments
Early passage (P15 or P19) SV-HUC-1 were exposed to MCA in three separate experiments (experiments I, II and III; Table I) using somewhat different protocols. In experiment I, SV-HUC-1 (P15) in continuous culture (never cryopreserved) were seeded at 1 x 10 6 viable cells/100-mm dish. Forty-eight hours after seeding, the growth medium was removed and replaced with serum-free F12 + to which was added 5 ^g/ml MCA for a 48-h exposure period. After the first 24 h of exposure, FBS (1%) was added to the F12+ medium. After an additional 24 h, the medium containing the MCA was removed and thereafter cells were cultured in 1 % FBS-F12 + until near confluence (10 days), and then dispersed and subcultured using a 1/3 split. SV-HUC-1 (now at P16) were then exposed again for 48 h to 5 ^g/ml MCA using the above protocol. After this second and final exposure to MCA, cells were cultured for 6 weeks and then inoculated as described below into nude mice (> 10 6 cells/site). During the subculture period, cells were kept in a proliferative state by always passing them before confluence (approximately every 10 days). At each subculture, cells were pooled, split 1/3 and excess cells were discarded. Therefore, although four dishes were maintained, these were not independent groups (in experiment I only).
In experiment II, SV-HUC-1 were treated with MCA for two 48-h periods at P15 and P16 respectively using the protocol described above, and were again subcultured as above for 6 weeks prior to inoculation (> 10 6 cells/site) into nude mice. However, in experiment II, each of the four groups at each concentration was maintained independently (cells were never pooled). In addition, three concentrations of MCA were used (1,5 and 10 /*g/ml), and the number of initial target cells in each group was adjusted according to the expected cell kill, so that each independent treatment group had -1 x 10 6 surviving cells after carcinogen treatment. Furthermore, the SV-HUC-1 (P19) cells used in experiment II (unlike those in experiment I) had not been in continuous culture, but were retrieved from a stock cryopreserved at P10.
In experiment HI, SV-HUC at P19 (also retrieved from a cell stock cryopreserved at passage 10) were exposed to a wider range of MCA concentrations (0.005-10 fig/ml) for 48 h using the same protocol as in experiment I with the following changes. Fewer cells (6 x 10 4 viable cells/group) were exposed only once to the carcinogen, rather than twice as in experiment I and II. In addition, SV-HUC-1 in experiment III were inoculated (> 10 6 cells/site) 2 weeks after the final carcinogen exposure, as well as 6 weeks (10 7 cells/site) after the carcinogen exposure (which was the time of the single inoculations in experiments I and II). Each of 22 different groups in experiment III were maintained independently (as in experiment II).
Non-established cultures of HUC were also exposed to MCA in two separate experiments also using the protocol used for SV-HUC-1 in experiment I. In each experiment, proliferating primary 7-day-old cultures of HUC (four independent groups, ~2 x 10 6 cells/each), were exposed to 0.5 /ig/ml MCA for a 48-h exposure period (as above). After recovery and subculture, HUC were again exposed to the same concentration of MCA. Lower MCA concentrations were used for HUC than SV-HUC-1 to achieve similar cytotoxic effects. A concentration of 0.5 ^g/ml MCA produced a level of cell survival (-50%) similar to that produced in SV-HUC-1 by 5.0 n g/ml MCA. Following expansion of the cultures, as above, cells were inoculated into athymic nude mice (>10 6 cells/site). Carcinogen-treated cells were also tested for other phenotypic markers of transformation including increased lifespan in vitro, the ability to form colonies in 0.3% agarose, and morphological changes using published protocols (27, 30) .
In all transformation experiments with HUC as well as SV-HUC-1, the control groups were treated, subcultured, and inoculated into nude mice at the same times and using the same methods and cell numbers as the carcinogen-treated groups. The only difference was that controls were treated with the DMSO solvent vehicle at the appropriate concentration (0.5%) in place of the carcinogen.
Inoculations of cells into nude mice
The tumorigenic potentials of control and carcinogen-treated cells were tested by inoculations into 4-6-week-old female athymic nude mice always from the same vendor (nu/AF, Harlan-Sprague -Dawley, Madison, WI). Mice were housed in laminar hoods in a temperature-(36°C) and humidity-(70%) controlled room. Control animals housed under these conditions lived a full lifespan. Inoculations were made s.c. always in the lower ventral quadrant using a volume of 0.2 ml/site. The range of cells inoculated was 1 -3 x 10 6 cells/site for all experiments, except the 6-week inoculation in experiment III, for which 10
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Initiation and characterization of cell lines from tumors
Cell lines were initiated using an explant technique (30) from some of the tumors produced in nude mice after inoculation of MCA-treated SV-HUC-1. The mouse skin and underlying stromal tissues were first trimmed away from the s.c. tumor mass. Tumor tissue was cut into 1-mm 2 explant fragments which were then plated onto collagen-gel substrates and cultured in 1% FBS-F12+ medium. Tumor cell lines (designated MC-SV-HUC Tl, T2, etc.) were characterized as soon as sufficient cells were available (P2 -P4). Standard indirect immunofluorescent staining techniques were used to test tumor cell lines for the presence of SV40 T-antigen (31), and human epithelial keratins (26) . The SV-HUC-1 cell line was used as a positive control for T-antigen, and normal HUC were used as a positive control for keratin. Tumor cell lines were also tested for the presence of infectious SV40 virus using the green monkey kidney plaque assay (32) . SV-HUC-2, a virusproducing SV40-transformed human uroepithehal cell line (23) was used as a positive control for SV40 virus production.
Karyotypic analyses
Karyotypic analyses were performed on Giemsa-banded chromosomes (23) . Proliferating cultures were exposed to 0.1 jig/ml colcemid (Gibco) for 6 h, dispersed with EDTA, treated with 75 mM KCI, and fixed with ice-cold methanol/acetic acid (3:1, v/v). Aliquots of the cell suspension were then dropped onto slides and allowed to air dry. For banding, the chromosome spreads were treated with 0.0125% trypsin solution, rinsed and stained with Giemsa (Gurr). To determine the modal numbers of each cell line, 50 chromosome spreads were counted. Karyotypic analyses were based on detailed examination of Giemsabanded chromosomes from 20 cells.
Analyses of p21 ras proteins
The mobilities of the p21 protein products of ras cellular proto-oncogenes were examined in seven tumor cell lines using sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) (33) in three separate experiments. Cells were labeled with [ 
Results
Neoplastic transformation of SV-HUC-1 by MCA
SV-HUC-1 were exposed to different concentrations of MCA (0.005-10 /tg/ml) in three separate experiments. In all experiments, MCA (>0.1 /ig/ml) was cytotoxic to SV-HUC-1 cells causing a maximum of -60% cytotoxicity at 10 fig/ml in experiment U (Table I ). The extent of MCA cytotoxicity was dependent on the concentration of MCA and was reproducible. For example, exposure of SV-HUC-1 cells to 5 /ig/rnl MCA for 48 h resulted in -50 ± 10% relative cell survival in three experiments (Table I) .
In all experiments, exposure of SV-HUC-1 to MCA resulted in neoplastic transformation of cells as determined by the ability of only the carcinogen-treated cells to produce tumors after s.c. inoculation (> 10 6 cells/site) into nude mice (Table I) . Morphological alterations were not observed in any of the treated dishes during the cultivation period before inoculation. However, it is unlikely that post-confluent focus formation (if it occurs in this system) would have been observed in these experiments as cells were always passed before confluence. The protocols used to transform SV-HUC-1 were somewhat different in the three experiments, and addressed several questions concerning the transformation event.
In the first two experiments, two separate 48-h exposures of SV-HUC-1 to MCA were used. However, in the third experiment, it was demonstrated that neoplastic transformation required only one 48-h exposure to MCA. Furthermore, in experiment III, 10-fold fewer initial target cells per independent group were used (<10 5 cells/group as compared to >10 6 cells/group in experiments I and II), and transformation was still detected. SV-HUC-1 cells from a cryopreserved stock (experiments II and HI), as well as SV-HUC-1 cells in continuous culture (experiment I) were both transformable by MCA. However, exposure of SV- Table I   Expt In experiments I and II, cells were subcultured for a total of 6 weeks after the final exposure to MCA before inoculation into /site) which gave tumors in MCA-treated cells inoculated after 6 weeks subculture in experiments I and II. However, in experiment II, the same cells which failed to produce tumors when inoculated only 2 weeks after carcinogen treatment were tumorigenic when inoculated (10 7 cells/site) after an additional 4 weeks of culture (Table I ). Thus, in these studies two treatments of cells with MCA were not essential for tumorigenic conversion, but a period of post-treatment culture longer than 2 weeks was apparently essential to detect tumorigenic transformants (with inoculations of -10 6 /site).
Histopathological and growth characteristics of the tumors
Subcutaneous inoculation of cells (including control cells) sometimes resulted in the formation of a small, soft (fluid-filled) benign urothelial cyst which disappeared within 2 weeks. In the present study, a tumor was defined as a hard palpable mass which arose and persisted after the initial swelling was gone. All the tumors produced after inoculation of MCA-treated SV-HUC-1 were carcinomas. However, independent tumors showed heterogeneity with respect to several characteristics, including histopathology and growth properties.
Two tumors (Tl and T3) were completely undifferentiated (type U) carcinomas showing neither glandular nor squamous differentiation. Both of these were high grade (grade IV) invasive cancers ( Figure 1A and B). T8 and T16 were also undifferentiated carcinomas, but both these cancers showed focal areas of pseudoglandular (g) differentiation, and were therefore designated as type Ug (Table I ). All of the other tumors examined (12/16) were classified as squamous cell carcinomas (type S). Most type S carcinomas showed prominent squamous cell differentiation with keratin pearl formation and/or deposition of large amounts of keratin ( Figure 1C-E) . All except one of the type S tumors in this study were sharply demarcated, non-invasive grade II carcinomas. T2 was a poorly differentiated grade III squamous carcinoma which was invasive to surrounding muscle and adipose tissues. All the tumors showed nuclear grade IV morphology.
All tumors except T16, were first observed 5 -8 weeks after inoculation. T16 appeared 5 months after inoculation. Some tumors of each histopathology (e.g. Tl, T2 and T16) grew rapidly and progressively continuing to increase in size reaching 1 -2 cm in diameter when removed. In general, type S tumors grew more slowly and averaged -3-5 mm in diameter when removed. However, one type S tumor (a transplanted T10) grew progressively and rapidly, and reached 1 cm in size before it was removed ( Figure IE) . In experiment II, some small tumors completely regressed (Table I) . Histopathology could not be done on tumors which regressed, but their size and growth properties were similar to slowly growing type S tumors. These small tumors (some of which regressed) were not remnants of the inocula as they always arose several weeks after the inoculation swelling had completely disappeared, and did not ever occur in over 50 inoculations of control cells. Furthermore, histopathologic examination of the cells surrounding the keratin-filled areas in small type S tumors showed highly mitotic anaplastic squamous carcinoma cells with grade IV nuclear morphology ( Figure ID) .
Spontaneous metastases to lungs, liver, kidneys or spleen from the s.c. sites of inoculation were not observed when these tissues were examined. Most of these tumors did not metastasize in the nude mice, even when injected by tail vein. However, one cell line derived from a type U tumor (Tl) metastasized to the lungs when inoculated i.v. in the tail. The details of these latter experiments will be presented in a separate paper.
Establishment and characterization of the tumor cell lines
Although cell lines were not initiated from all of the 16 tumors histologically examined (Table I) , seven tumor cell lines (MC-SV-HUC Tl, T2, T7, T9, T10, Til and T16) were established from primary tumors, representing the three experiments and the different histopathologic tumor types (U, S and Ug) described above ( Table I) .
The morphology of the cells which grew out from the primary explant cultures of tumor pieces was epithelial. The tumor cells at first formed smooth tightly adherent sheets, similar to those seen in primary cultures of HUC (Figure 2A ) and in the SV-HUC-1 line ( Figure 2B ). However, after ~2 weeks in culture, cells in many tumor explant cultures (e.g. T7, T9, T10 and Tl 1) showed altered morphology compared with HUC and SV-HUC-1 and formed numerous multi-layered nodules ( Figure 2C ), and in one culture (T9) an umbrella-shaped frond ( Figure 2E and F) . These structures were similar to those formed in primary explant cultures of specimens of human bladder cancers grown using the same culture conditions (30) . Once passaged, the altered morphology was not seen (Figure 2D) , and the tumor cell lines all looked similar and resembled the parental SV-HUC-1 cell line.
To confirm that the cell lines (and the tumors) were derived from SV-HUC-1 (and not from host mouse cells), chromosome analyses were done. All cells in all cell lines initiated from tumor explants contained only human chromosomes (see below). In addition, all cells examined in all of the tumor cell lines tested positive for epithelial cytokeratins and nuclear SV40 T-antigen (data not shown). All tumor cell lines also tested negative for the presence of infectious SV40, as did the parental SV-HUC-1 line. Thus, all the tumors were of human epithelial origin and all derived from SV-HUC-1.
All of the tumor cell lines have been re-inoculated into athymic nude mice (3.0 x 10 6 cells/site) to determine if the cells retain their tumorigenic phenotype. All tumor cell lines except MC-SV-HUC T9 and MC-SV-HUC Tl 1 gave rise to tumors on re-inoculation. The histopathologies and growth properties of the tumors obtained after inoculation of the tumor cell lines were basically the same as those of the primary tumors, except one tumor cell line (T10) gave rise to a more rapidly growing type S tumor (Figure 1 , compare C and E). Another tumor line (T16) which had been classified as type Ug (because it was an undifferentiated carcinoma showing areas of glandular differentiation) caused tumors on re-inoculation with both glandular (g) and squamous (s) differentiation. These were then classified as mixed carcinomas (type M).
Cytogenetic analysis of the tumor cell lines
Chromosome analyses showed aneuploid human karyotypes with the retention of SV-HUC-1 marker chromosomes and the formation of new marker chromosomes in all tumor cell lines. A detailed analyses of chromosome marker formation in six independent tumor lines will be published elsewhere. Here we present three karyotypes (parental SV-HUC-1, MC-SV-HUC Tl and MC-SV-HUC T9) in Figure 3 , panels A, B and C respectively. The seven marker chromosomes identified in SV-HUC-1 are 5p + , 6p+, 9q + , llp+, 15q-, 19p+andXp + (23, 35) . MC-SV-HUC Tl cells (experiment I, type U) retained three of seven SV-HUC-1 marker chromosomes (5p+, 19p + and Xp+) and have gained five new marker chromosomes (3p+, 4p + , 6q-, 8q+ and 12p+). MC-SV-HUC T9 have retained three SV-HUC-1 marker chromosomes (9q+, 19p+ and Xp+) and have gained four new marker chromosomes (5p+, 6q -, llp+ and 14p + ). The Tl 6q-and T9 6q-were formed by different mechanisms. The 5p+ and 1 lp+ markers in the tumors are different from those to SV-HUC-1. Tl has an apparent monosomy of chromosome 9 with 9p lost and 9q involved in marker formation. Both Tl and T9 have apparent monosomies of chromosome 13. Loss and/or additional rearrangements of parts of number 15 chromosomes were seen in all tumor cell lines. Tl cells have lost the short arm of 3 ( -3p) in the rearrangment which led to the formation of the 3p+ marker. All the marker chromosomes of a given tumor cell line were present in essentially all cells and were unique to that tumor line, thus demonstrating the independent derivation of the tumor cell lines and the apparent clonal origin of each cell line.
Analyses of the p21 ras encoded proteins
All of the seven tumor cell lines were tested for the presence of mutations in ras cellular proto-oncogenes which result in altered mobilities of the p21 protein products. Using an SDS-PAGE analyses of proteins precipitated by antibody to the p21 ras protein product, none of the seven tumor cell lines (Tl,  T2, T7, T9, types (HUC and SV-HUC-1) showed altered mobility of these proteins in the same gel which showed the expected altered mobilities (34) of the p21 ras protein products of the T24 and HS242 cell lines (Figure 4) . Failure of MCA to transform HUC Two separate transformation experiments were done using normal human uroepithelial cells initiated from two different kidney donors. HUC were exposed to five concentrations of MCA (in the range 0.5 -15/ig/ml) using the same protocol which successfully transformed SV-HUC-1 in experiment I (Table I) . No morphological changes were observed in the carcinogentreated cells and control and treated cultures senesced after ~ 35 doublings (four passages) which is characteristic of HUC (27) . In addition, neither the control HUC nor carcinogen-treated HUC formed any colonies in semi-solid agarose or produced tumors in nude mice (data not shown). In summary, treatment of HUC with MCA using the same protocol successfully used to transform immortalized SV-HUC-1 did not result in acquisition by these non-established cells of any of the above phenotypic markers associated with partial or complete cellular transformation in vitro.
Discussion
Reproducible neoplastic transformation in vitro of human epithelial cells has been difficult to achieve and has limited the use of these cells for studies of the mechanisms of chemical carcinogenesis (20) . The present report describes the first in vitro neoplastic transformation of human urinary tract epithelial cells. Neoplastic transformation of HUC was achieved using a stepwise procedure and was the result of the combined actions of SV40 and MCA, as neither of these agents alone neoplastically transformed HUC. A similar stepwise strategy was used successfully to neoplastically transform adenovirus 12 -SV40 hybrid virus (AD12-SV40) immortalized human keratinocytes (21, 22) . Neoplastic transformation of SV-HUC-1 by MCA was readily reproduced with multiple independent groups in three experiments using cells which had been cryopreserved as well as cells maintained continuously in culture.
We do not propose that MCA will transform all SV40-immortalized lines. Another independently derived SV40-immortalized HUC line (SV-HUC-2) (23), was not transformable by MCA using the experiment II protocol described above. Currently, we are testing the transformability of several other SV40-immortalized lines of human uroepithelial cells using a variety of carcinogens. The details of these experiments will appear elsewhere.
Although MCA is not an environmental bladder carcinogen, it is a potent experimental carcinogen when tested in many systems both in vitro and in vivo, including mouse bladder epithelium (36, 37) . The mechanism by which MCA transforms SV-HUC-1 is not yet known. However, it is unlikely that the production of tumors after inoculation of MCA-treated SV-HUC-1 is a result of the selection of rare tumorigenic variants in the SV-HUC-1 cell line, because the concentrations of MCA that transformed SV-HUC-1 killed only half the cells (Table I) . Furthermore, SV-HUC-1 has remained consistently nontumorigenic throughout an extensive cultivation period in vitro as determined by > 50 routine inoculations into nude mice using as many as 10 cells/site. In contrast, a single exposure of SV-HUC-1 to MCA resulted in neoplastic transformation. But, tumors were not obtained unless carcinogen-treated cells were permitted a period of post-treatment cell proliferation. Similar long periods of cell proliferation were also required before transformation was seen in human diploid cells treated with chemical carcinogens (38) (39) (40) (41) , X-rays (42, 43) , and UV light (44) . It is not clear if this period of cell proliferation is required to permit further expansion of the number of transformed cells in such cultures, or if further genetic changes (such as loss of tumor suppressor genes) may take place during this time. This later hypothesis is consistent with our data showing chromosome losses and rearrangements in the tumor cells (see below).
The endpoint used to test for neoplastic transformation in the studies reported here was the ability of cells to produce carcinomas in athymic nude mice. The nude mouse model has proved to be a reliable test system (45) . In general, when human cancers are transplanted into the nude mouse, human tumors arise with unchanged histopathology. Increased ability of cells to grow in semi-solid medium, which is a good correlate of transformation in many systems (46), was not a useful marker in our system as this characteristic was spontaneously acquired by passaged SV-HUC-1 in the absence of neoplastic transformation (23) . Focus formation, a useful marker for neoplastic transformation in many fibroblast systems (e.g. 47) is not a feature commonly associated with chemically transformed epithelial cells (e.g. 46) and was not observed in MCA-treated SV-HUC-1 cells in this study. Because of a lack of a quantitative marker of transformation and the requirement of treated cells for a period of proliferation before inoculation, it was not possible to determine the number of transformants in each group. However, it is possible using experiment III data to estimate an approximate minimal transformation frequency of at least one transformant per 3 X 10 4 cells surviving the carcinogen treatment (Table I) .
In this study, several heterogeneous tumor histopathologies were observed including undifferentiated carcinomas (with or without focal areas of glandular differentiation), poorly differentiated and well differentiated squamous carcinomas, and mixed carcinomas (in tumors obtained when the T16 tumor line was inoculated into nude mice). The tumors ranged from grade II to grade IV, but all showed nuclear grade IV morphology. Some tumors grew rapidly; while others grew slowly. Four tumors were invasive, but only one formed colonies in the lung when single cells were inoculated into the mouse tail vein. Thus, we can say that the properties of the cancers induced in the SV-HUC-1 cell lines were heterogeneous, and in this respect, these in vitro transformants recapitulated the potential for heterogeneity seen in human clinical bladder cancers (28) . It is striking, however, that the histopathology most commonly seen in human bladder cancers, transitional cell carcinoma, was not seen in the tumors induced in this study. We cannot yet explain this result. This result is particularly intriguing because when SV-HUC-1 cells are transfected with the activated c-Ha-ras-1 oncogene, carcinomas with transitional (but not squamous) differentiation are produced (48) . Thus, it is clear that at least some of the cells in the SV-HUC-1 line have the potential to be tumorigenically transformed to cells which form transitional cell carcinomas. There is only one example that we have found in the literature of transformation of rodent bladder epithelium by MCA (36, 37) . In this in vivo study, it was also observed that in most cases metaplasia to squamous epithelium developed coincidentally with malignant changes in the bladder epithelium (37). Thus, it is possible that the carcinogen used to transform the SV-HUC-1 cells in a way (not yet understood), directs the type of malignancy that is obtained.
Some (but not all) of the small tumors in this study regressed in the third and fourth month after inoculation. Although pathology was not done on these tumors, their growth properties were similar to the keratin-filled type S tumors. Apparently, similar keratin-filled nodules which regressed formed following inoculation into nude mice of 10 7 AD12-SV40-immortalized keratinocytes which were not exposed to carcinogens (21, 22) . In contrast, in our study, keratinizing nodules were never formed after inoculation of similar numbers of untreated SV-HUC-1, but only after inoculation of SV-HUC-1 exposed to MCA. Furthermore, small tumors gave rise to tumor cell lines (e.g. T10) which caused tumors on re-inoculation. Thus, the small tumors appear to represent a stage of neoplastic transformation, albeit not as malignant a phenotype as other tumors obtained in this study. The spontaneous conversion of one slowly growing type S tumor (T10) to a more aggressive type S tumor, after a relatively short (five passages) culture period may represent malignant progression. In this regard, control SV-HUC-1 cells did not spontaneously transform even after 80 passages in vitro. Small persistent keratin-filled nodules, resembling differentiated squamous carcinomas, have also been observed following inoculation into nude mice of hybrid cells formed by the fusion of HeLa carcinoma cells and normal human keratinocytes (49) . These latter results suggest that the normal keratinocytes donated genes to the HeLa hybrid causing keratinization and a less malignant phenotype. This observation is consistent with the observation that squamous cell carcinomas do not grow progressively if the tumor cells differentiate at a greater rate than they proliferate (50, 51) . Such a mechanism may explain the regression of some type S tumors in our study. These observations support the hypothesis that malignant conversion and progression may require loss of normal genes, as well as activation of oncogenes.
Human bladder cancers also show heterogeneous properties. For example, bladder carcinomas show heterogeneity with respect to their growth properties in vivo. Some bladder tumors remain superficial forming papillary growths, while others grow aggressively, invade and metastasize (11 -13) . Human bladder cancers also show heterogeneity in histopathology. Although transitional carcinomas and undifferentiated urothelial carcinomas are more common, bladder cancers with squamous differentiation (such as we have seen in our study) are not uncommon and predominant in some areas (28) . Human bladder cancers show a variety of chromosomal changes, but alterations involving chromosome numbers 1, 3, 5, 6, 8, 9, 11 and 13 are most frequently reported (17) (18) (19) . The tumors analyzed in this study showed changes involving most of the same chromosomes (3, 5, 6, 8, 9, 11 and 13) altered in clinical bladder cancers. Two undifferentiated tumors in our series whose karyotypes were examined (Tl and T16) showed a deletion of 3p, which is sometimes reported lost in human bladder cancers (17 -19) , but frequently non-randomly lost in several other human carcinomas (52) (53) (54) . These results suggest to us that 3p may hold genes which act as cancer suppressor genes for several human epithelial cell types. A more detailed analysis of these cytogenetic changes will appear elsewhere.
Although, activated ras genes have been identified in some cells transformed both in vivo and in vitro by MCA (55, 56) , in the present study, activation of ras genes in MCA-transformed SV-HUC-1 by common point mutations resulting in altered mobilities of the p21 ras proteins has so far not been detected using SDS-PAGE analysis. However, activated ras genes are not associated with the vast majority (90%) of clinical bladder cancers (13) (14) (15) . Thus, in this respect, the in vitro neoplastic transformants of human uroepithelial cells recapitulate a molecular genetic characteristic observed in most human clinical bladder cancers.
It will be important to examine further the molecular genetic changes in the neoplastically transformed cells obtained in this study, especially as mutational activation of raj is apparently not involved in the tumorigenic transformation step. Furthermore, it will also be very important to determine the transforming capability of bladder-specific environmental carcinogens and/or their reactive metabolites toward this transformable human uroepithelial cell line, and to determine what type of cancers are induced and if ras or other cellular proto-oncogenes are activated. Analyses of such transformants would be even more relevant to understanding the genetic mechanisms of human bladder carcinogenesis.
